Introduction
Fluorene and its derivatives are versatile reagents which are used in wide range of synthetic applications [1] . Fluorene-based aromatic ketones are of profound interest as building blocks for the production of drugs, pharmaceuticals and industrial fine chemicals [2, 3] particularly in the production of lubricating and thermosetting plastic materials. Furthermore, fluorene-based polymers and copolymers are of interest owing to their unusual optical and electrical properties and therefore are usually used in organic light-emitting diodes, flat panel displays and in solar cells [4, 5, 6] .
Benflumetol is a racemic fluorene derivative, which mimics the structure and reactivity of the arylamino alcohol group of antimalarial drugs such as quinine, mefloquine, and halofantrine ( Fig. 1 ) and is used as antimalarial agent in combination treatment with artemether [7] . In the synthesis of benflumetol, 2,7-dichloro-4-(chloroacetyl)fluorene is an important intermediate [8] . Interestingly, N-arylaminoacetyl, N-alkylaminoacetyl, and N-dialkylaminoacetyl derivatives are reported to exhibit a wide spectrum of pharmacological activities such as antitumor, anti-inflammatory, antibacterial, antiviral, antitubercular and anti-arrhythmic activity [9, 10, 11] .
In cellular functions, dihydrofolate reductase (DHFR) is an enzyme that reduces 7,8-dihydrofolate (DHF) to 5,6,7,8-tetrahydrofolate (THF) using NADPH as electron donor:
which is the precursor of the co-factors required for the biosynthesis of purine nucleotides, thymidine (precursor for DNA replication) and several amino acids [12] . Thus, inhibition of DHFR can lead to the disruption of DNA synthesis and the death of the cancer cells [12, 13] . In addition to this, bacteria also need DHFR to grow and multiply and hence inhibitors selective for bacterial vs. host DHFR have found application as antibacterial agents [14] . These two important factors make the enzyme a key target for both antibacterial and antitumor drug design in cancer chemotherapy. Based on these previous findings, we envisaged that the hybridization of the versatile 2,7-dichlorofluorene moiety with α-N-aryl-, N-alkyl, Ndialkylamino acetyl pharmacophores into a single chemical entity could be effective in enhancing its anticancer and antimicrobial properties. To achieve this, our previous experience in the synthesis of new antimicrobial and anticancer agents was helpful [15, 16, 17] . In the present work, we have synthesized some new 2,7-dichloro-4-(2-substitutedamino acetyl)fluorenes and studied their cytotoxic activity against human lung carcinoma (A-549) and human breast carcinoma (MCF-7) cell lines followed by antimicrobial and molecular docking studies.
Results and discussion

Chemistry
In this present work, our goal deals with the design and synthesis of some new 2,7-dichloro-4-(2-substituted-amino acetyl)fluorene derivatives combining different N-aryl/alkyl-amino acetyl groups with the biologically active 2,7-dichlorofluorene moiety on the antimicrobial and antitumor activities. In addition, a structure-activity relationship (SAR) study with different aromatic and aliphatic substituents was also carried out. As the DHFR inhibition is regarded as one of the most outstanding mechanism in exerting antimicrobial and antitumor activities [18, 19, 20] , the synthesized compounds were designed to: (a) mimic the pharmacophores that may act as DHFR inhibitors; (b) possess hydrophilic and hydrophobic moieties that can interact with the hydrophilic and hydrophobic parts of the DHFR active site, respectively (Fig. 2) .
The present strategy for the synthesis of the target compounds 4a-u is outlined in Schemes 1 and 2. It starts with a convenient and straightforward approach to 2,7-dichlorofluorene (2) involving direct chlorination of fluorene (1) by means of N-chlorosuccinimide (NCS) in acetic acid in the presence of hydrogen chloride [21] . The chloroacetylation of 2 is accomplished by adding a solution of 2 in dichloromethane at 0-5 C to a suspension of aluminum chloride and chloroacetyl chloride in dichloromethane (DCM). The reaction mixture is then quenched with diluted hydrochloric acid, after phase separation and washing, dichloromethane is evaporated under reduced pressure and cooled ethanol was added. The corresponding 2,7-dichloro-4-(chloroacetyl)fluorene (3) is isolated in 95% yield by filtration and drying (Scheme 1) [22] . The target 2,7-dichloro-4-(2-substituted-amino acetyl)fluorenes 4a-u are obtained in moderate-excellent yields (58-96%) by simple nucleophilic substitution reaction of the chloroacetyl derivative 3 with different primary and secondary aryl-, alkyl-amines in dimethylformamide as reaction medium (Scheme 2).
The structures of all synthesized compounds 4a-u were confirmed on the basis of FT-IR, 1 H-NMR, 13 H-NMR spectrum showed three singlet signals at 7.95, 7.23, 7.07 ppm, two doublets at 6.98 and 6.88 (J ¼ 7.0 Hz) for five protons of the fluorene moiety. Two doublets at 7.85 and 6.80 ppm (J ¼ 8.5 Hz) appeared for the protons of 4-chlorophenyl moiety. In addition to this, NH proton appeared as a singlet signal at 5.27 ppm and the two singlet signals at 3.97 and 3.91 ppm corresponded to the two methylene protons.
Biological activity
Antimicrobial activity
The novel compounds were assessed for antimicrobial activity against two strains of Gram þ ve bacteria namely S. aureus (RCMB010010), and B. subtilis RCMB 015 (1) NRRL B-543 as well as two strains Gram -ve bacteria namely E. coli (RCMB 010052) ATCC 25955, and P. vulgaris RCMB 004 (1) ATCC 13315. The strains A. fumigatus (RCMB 002008), and C. albicans RCMB 005003 (1) ATCC 10231 were employed in assessment of antifungal activity.
The result of the antimicrobial assay of the synthesized compounds is given in Table 1 and Fig. 3 . It is observed that some of the compounds showed increased antimicrobial activity when compared to the reference drugs. These compounds have given the best results in the inhibition of different types of bacteria and fungi; compound 4m against the S. aureus and B. Subtilis with zone of inhibition (ZOI) values 18 and 17, respectively, compounds 4h and 4m against E. coli, ZOI value 14, compound 4u against P. vulgaris ZOI value 15, compounds 4h, 4r and 4u against A. fumigatus, ZOI values 22, 24 and 20, respectively, compound 4h against C. albicans, ZOI value 18. From the previous results we observed that, both compounds 4h and 4u are active as antimicrobial agents (have Scheme 2. Synthetic routes to the target compounds 4a-u. Table 1 Anti-microbial activity of newly synthesized compounds 4a-u (tested at 10 mg/ml) and expressed as the mean inhibition zone in mm AE standard deviation. antibacterial and antifungal activities), while compound 4r and 4m exhibited only antifungal and antibacterial activity, respectively.
In vitro anticancer activity
The tested compounds were screened for their cytotoxic activity against human lung carcinoma (A-549) and breast carcinoma (MCF-7). Their IC 50 value, the concentration which can inhibit 50% of viable cells, was determined and data are showed in Tables 2 and 3 . The reference control in this study is 5-Fluorouracil (5-FU).
From the obtained results in Tables 2 and 3 Fig. 4 , the order of the cytotoxic activity of the tested compounds against human lung carcinoma (A-549) followed the order 4k
However, the potency of cytotoxicity of the tested compounds against human breast carcinoma cell line (MCF-7) has following order 4k
The results of this biological screening for the synthesized compounds may lead improvement of the anticancer agents. Over all, from the biological evaluation results, it can be clearly concluded that the synthesized compounds 4g, 4r, 4u and 4m have dual activities (they are active as both antimicrobial and anticancer agents).
Docking and molecular modeling study
Literature survey [19, 23] proved that thymidylate synthase and dihydrofolate reductase (DHFR) were used in the development of anticancer and antimicrobial agents. In the present investigation, Molecular Operating Environment (MOE) module was accomplished to justify the cytotoxic potency of the tested compounds [24] . Furthermore, study of the Molecular docking help in well knowing the action of any compound via their different interactions with the active sites of DHFR. Docking was performed for the compounds 4a-4u on DHFR to predict their action as anticancer agents (c.f. SI file). All the tested compounds show different interactions with the active site of DHFR. Especially, the tested Table 3 In vitro anticancer screening of the synthesized compounds against human breast carcinoma cell line (MCF-7). Fig. 4 . Comparison of the cytotoxic activity of the tested compounds 4a-u against human lung carcinoma (A-549) and human breast carcinoma (MCF-7). (Table 4 in SI file). The docking score energy for the newly synthesized compounds follows the order: (Fig. 5) . (Fig. 6 ).
Conclusion
We report herein the synthesis of a new series of 2,7-dichloro-4-(2-substituted-amino acetyl)fluorene derivatives. Most of these new compounds exhibited significant anticancer activity against human lung carcinoma (A-549) and human breast carcinoma (MCF-7) cell lines, when compared to 5-Fluorouracil as a reference drug. In addition, on the antimicrobial evaluation; some of these synthesized compounds showed acceptable activity as antibacterial and antifungal agents. To the best of our knowledge, these multi-addressable properties of the new synthesized 2,7-dichlorofluorene derivatives described in this work will open a new alternative era in the field of medicinal chemistry and can be considered as pharmacophores.
Experimental
Chemistry
General methods
All Chemicals and solvents used purchased from Sigma-Aldrich are spectroscopic grade and used without further purifications. Melting points were determined on a Stuart SMP3 melting point apparatus and are uncorrected. FT-IR spectra were recorded on a Shimadzu IR-3600 FT-IR spectrometer in KBr pellets. NMR spectra were acquired on a Bruker Avance 500 instrument (500 MHz for In two necked flask, a suspension of chloroacetyl chloride (4 g, 0.036 mol) and AlCl 3 (6 g, 0.045 mol), in dichloromethane (20 mL) was cooled to -5 C. A solution of 2 (6 g) in dichloromethane (50 mL) was added dropwise over about 1 h. After 10 h, the deep-red reaction mixture was quenched with aqueous hydrochloric acid (100 mL). After phase separation, the organic layer was washed three times with distilled water. Dichloromethane was distilled off under reduced pressure. Cold ethanol was added and the crystallized product was filtered-off to give 7.65 g (95%) of pure chloroacetyl derivative 3 as colorless crystals, mp 122-123 C (lit [8] . m. p. 124-125 C). 
Synthesis of 2,7-dichloro-4-(2-substituted-amino acetyl)fluorenes 4a-u
A mixture of chloroacetyl derivative 3 (0.001 mol) and different aryl/ alkyl amine (0.001 mol) in dimethylformamide (10 mL) was refluxed for 4-6 h. The reaction mixture was cooled to room temperature and poured onto ice/water mixture, the obtained solid product was filtered, washed with cold ethanol then with n-hexane, dried and recrystallized from ethanol to give the titled products 4a-u. (br s, 2H, C 1 -H, C 3 -H 1-(2,7-Dichloro-9H-fluoren-4-yl)-2-(4-(4-(trifluoromethyl) 
In vitro anticancer screening
The cell lines were purchased from the American Type Culture collection and their accession number as follows: A-549 (ATCC CCL-185™) lung carcinoma cell line and MCF-7 (ATCC HTB-22™) breast adenocarcinoma cell line. Cytotoxic activity screening was performed at Regional Center for Mycology and Biotechnology, Al-Azhar University, according to the suggested method of Skehan et al. [28] . Cells were plated in 96-multiwell micro titer plates (10 4 Tables 2 and 3. 
